<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6410043\results\search\tropicalVirus\results.xml">
  <result pre="The recent explosive pandemic of chikungunya virus (CHIKV) followed by" exact="Zika" post="(ZIKV) virus infections occurring throughout many countries represents the"/>
  <result pre="the clinical picture associated with these acute arbovirus infections, including" exact="Dengue" post="(DENV), CHIKV and ZIKV, ranges from classical febrile illness"/>
  <result pre="picture associated with these acute arbovirus infections, including Dengue (DENV)," exact="CHIKV" post="and ZIKV, ranges from classical febrile illness to life-threatening"/>
  <result pre="ZIKV, ranges from classical febrile illness to life-threatening disease. Whereas" exact="ZIKV" post="and CHIKV-mediated infections have previously been recognized as relatively"/>
  <result pre="previously been recognized as relatively benign diseases, in contrast to" exact="Dengue" post="fever, recent epidemic events have brought waves of increased"/>
  <result pre="two major families: (i) the Flaviviridae (genus flavivirus) which includes" exact="West Nile" post="(WNV), yellow fever (YFV), dengue (DENV) and Zika (ZIKV)"/>
  <result pre="includes West Nile (WNV), yellow fever (YFV), dengue (DENV) and" exact="Zika" post="(ZIKV) viruses and (ii) the Togaviridae (genus alphavirus) to"/>
  <result pre="viruses and (ii) the Togaviridae (genus alphavirus) to which belong" exact="Chikungunya" post="(CHIKV), Ross River (RRV) and Sindbis (SINV) viruses [1,2]."/>
  <result pre="humans [4]. In contrast to the typically sylvatic outbreaks of" exact="CHIKV" post="that occur in Africa, a single amino acid mutation"/>
  <result pre="amino acid mutation in the E1 envelop protein adapted the" exact="CHIKV" post="to Ae. albopictus, a vector that readily adapts to"/>
  <result pre="these infectious diseases with a staggering economic burden. For example," exact="DENV" post="causes more than 50 million infections yearly with more"/>
  <result pre="associated with neurological disorders and neonatal malformations in Latin America," exact="YFV" post="outbreaks in Angola and Brazil, WNV in North America,"/>
  <result pre="malformations in Latin America, YFV outbreaks in Angola and Brazil," exact="WNV" post="in North America, as well as the emergence of"/>
  <result pre="WNV in North America, as well as the emergence of" exact="CHIKV" post="from sub-Saharan Africa in the not-too-distant past and its"/>
  <result pre="the dermis, which represents the first stage of infection. Both" exact="DENV" post="and ZIKV have been shown to infect dermal dendritic"/>
  <result pre="which represents the first stage of infection. Both DENV and" exact="ZIKV" post="have been shown to infect dermal dendritic cells (DCs)"/>
  <result pre="dendritic cells (DCs) and although there are no reports of" exact="YFV" post="infecting Langerhans cells, it can nevertheless infect myeloid DCs."/>
  <result pre="nevertheless infect myeloid DCs. Viral entry into susceptible cells during" exact="ZIKV" post="infection is mediated by DC-SIGN but appears to be"/>
  <result pre="DC-SIGN but appears to be DC-SIGN-independent in the case of" exact="DENV" post="and YFV [8]. It has been shown that CHIKV"/>
  <result pre="appears to be DC-SIGN-independent in the case of DENV and" exact="YFV" post="[8]. It has been shown that CHIKV is able"/>
  <result pre="of DENV and YFV [8]. It has been shown that" exact="CHIKV" post="is able to replicate in epithelial and endothelial cells"/>
  <result pre="(Figure 2). In a zebrafish model, it was shown that" exact="CHIKV" post="rapidly disseminates to various organs within approximately 14 h"/>
  <result pre="prominent and prolonged arthralgia with CIKV infection, haemorrhagic fever with" exact="DENV" post="infection and microcephaly and other neurological manifestations with ZIKV"/>
  <result pre="with DENV infection and microcephaly and other neurological manifestations with" exact="ZIKV" post="infection [1,6,16]. It is however important to note that"/>
  <result pre="by arboviruses induces a long-term protection, as recently demonstrated for" exact="CHIKV" post="[17]. DENV is an excellent example of the opposite"/>
  <result pre="induces a long-term protection, as recently demonstrated for CHIKV [17]." exact="DENV" post="is an excellent example of the opposite situation, with"/>
  <result pre="long-term protection against infection by other serotypes. Furthermore, heterotypic secondary" exact="DENV" post="infection, with a DENV type distinct from the primary"/>
  <result pre="by other serotypes. Furthermore, heterotypic secondary DENV infection, with a" exact="DENV" post="type distinct from the primary infecting type, is the"/>
  <result pre="the primary infecting type, is the greatest risk factor for" exact="Dengue" post="haemorrhagic fever/dengue shock syndrome (DHF/DSS) [18]. It has been"/>
  <result pre="anti-DENV antibodies is directly associated with the severity of secondary" exact="DENV" post="disease in humans. 1.3. NK Cells: A Critical First-Line"/>
  <result pre="helicase motif 1b region of related flaviviruses, including DENGV, ZIKV," exact="YFV" post="and Japanese encephalitis viruses, to KIR2DS2. The other activating"/>
  <result pre="encompassing over 2 million suspected infections from the arrival of" exact="CHIKV" post="in 2013, an alphavirus associated with chronic and debilitating"/>
  <result pre="debilitating polyarthralgias (Pan American Health Organization 2017. http://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=readall&amp;amp;cid=5927&amp;amp;Itemid=40931&amp;amp;lang=en). In 2008," exact="CHIKV" post="was listed as a US National Institute of Allergy"/>
  <result pre="role of NK cells was mostly examined in detail for" exact="CHIKV" post="infection. Although we and others have shown that NK"/>
  <result pre="NK cells mount an early and efficient protective response following" exact="CHIKV" post="infection, their contribution to viral-induced pathology has been reported"/>
  <result pre="been previously observed in other viral infections [20,50]. More intriguingly," exact="CHIKV" post="infection skews the NK cell receptor repertoire toward expression"/>
  <result pre="individuals. Similar observations have been made in the context of" exact="CHIKV" post="[45], Hantavirus [52] and viral hepatitis B and C"/>
  <result pre="animal models [59,60]. It is clear that NK cells in" exact="CHIKV" post="infection are strongly cytotoxic without producing IFN-γ, thereby suggesting"/>
  <result pre="of infection [45]. Thus, in an experimental mouse model of" exact="CHIKV" post="infection, extension of oedema was correlated with high NK"/>
  <result pre="cells appear to be beneficial in the acute phase of" exact="CHIKV" post="infection. Nevertheless, NK cells could contribute to immunopathologic mechanisms"/>
  <result pre="single vaccination (http://www.who.int/mediacentre/factsheets/fs100/en/). However, despite the success of this vaccine," exact="YFV" post="continues to circulate in the tropical jungles of Africa"/>
  <result pre="and South America and re-emerges regularly to infect naïve persons." exact="WNV" post="is even more widely dispersed because it infects a"/>
  <result pre="5 years, the virus had dispersed throughout the Americas [65]." exact="DENV" post="fever remains an important disease caused by four closely"/>
  <result pre="remains an important disease caused by four closely related viruses," exact="DENV" post="1–4, for which no DENV-specific therapies are available. The"/>
  <result pre="for which no DENV-specific therapies are available. The sole approved" exact="DENV" post="vaccine elicits protection in people with prior DENV exposure"/>
  <result pre="sole approved DENV vaccine elicits protection in people with prior" exact="DENV" post="exposure but not in naïve individuals in which it"/>
  <result pre="in which it has been associated with more cases of" exact="DENV" post="haemorrhagic fever upon subsequent infection [66]. Another important question"/>
  <result pre="first cell types to be infected by flaviviruses such as" exact="DENV" post="or ZIKV. The DCs are specialized in the production"/>
  <result pre="tissue-specific localizations are consistent with the generally accepted finding of" exact="DENV" post="infection that often results in &quot;petechiae�? following resolution of"/>
  <result pre="viral load in the brains of CXCR3-deficient mice infected by" exact="DENV" post="[72]. NK cells have been studied, to various extent,"/>
  <result pre="studied, to various extent, in several flavivirus infections, including DENV," exact="WNV" post="and ZIKV. Generally, in these infections, an early and"/>
  <result pre="dengue disease [15,73] and was also observed in children with" exact="DENV" post="haemorrhagic fever [58]. In addition, an extensive phenotypic study"/>
  <result pre="receptors NKp30, NKp44, NKp46 and NKG2D in patients infected by" exact="DENV" post="[73,74] or WNV [75]. A transient increase in the"/>
  <result pre="NKp46 and NKG2D in patients infected by DENV [73,74] or" exact="WNV" post="[75]. A transient increase in the frequency of adaptive"/>
  <result pre="previously described for CHIKV, whereas the most prominent response in" exact="WNV" post="infection was observed among CD56dimCD16− NK cells, an intermediate"/>
  <result pre="was observed that the activation state of NK cells in" exact="DENV" post="infection was short-lived [46], suggesting that there is no"/>
  <result pre="imprint on the NK cell repertoire, as previously observed in" exact="CHIKV" post="infection [45]. It is important to note that following"/>
  <result pre="compared with healthy controls [33,79,80]. Mechanistically, KIR molecules interact with" exact="DENV" post="peptides presented on HLA molecules. As observed in many"/>
  <result pre="was demonstrated between KIR3DL1 and a conserved NS1 peptide of" exact="DENV" post="presented by HLA-B57 [82]. By contrast, a peptide on"/>
  <result pre="As in several other human viral infections (e.g., CMV, hantavirus," exact="CHIKV" post="and HIV-1), we observed an early accumulation of NKG2C+"/>
  <result pre="infection [46]. Of note, in other flavivirus infections, such as" exact="WNV" post="and tick-borne encephalitis (TBEV), another flavivirus transmitted to humans"/>
  <result pre="Consistently, a direct interaction of NKp44 and protein E of" exact="DENV" post="and WNV has been observed [87]. These data suggest"/>
  <result pre="direct interaction of NKp44 and protein E of DENV and" exact="WNV" post="has been observed [87]. These data suggest that this"/>
  <result pre="activity, leading to the inhibition of NK cell function. In" exact="WNV" post="infections, this modulation is associated with upregulation of NKG2D"/>
  <result pre="be inhibited by blocking IFN-β [89]. Other flaviviruses such as" exact="WNV" post="are associated with activation of NF-κB, as shown after"/>
  <result pre="of NF-κB, as shown after infection of IFNAR(−/−) cells by" exact="WNV" post="[90]. Furthermore, it was reported that HLA-E is upregulated"/>
  <result pre="[90]. Furthermore, it was reported that HLA-E is upregulated in" exact="ZIKV" post="but not in DENV-infected NK cells, suggesting a differential"/>
  <result pre="human NK cells was found to be important in controlling" exact="DENV" post="replication in the absence of cytotoxicity [70]. Upregulation of"/>
  <result pre="of IFN-γ production by NK cells was also observed in" exact="WNV" post="infection both before and after NK cell expansion [92]."/>
  <result pre="microenvironment were associated with lower viral loads following vaccination against" exact="YFV" post="[78]. Nevertheless, it is important to note that an"/>
  <result pre="was reported in liver biopsies of patients who died of" exact="YFV" post="[93]. There are two mechanisms by which a viral"/>
  <result pre="school children in Thailand prior to a secondary infection with" exact="DENV" post="appeared to correlate with neutralizing Ab titres and immune"/>
  <result pre="examined in patients infected by DENV. Similarly, NK cells control" exact="WNV" post="infection by detecting and lysing NS1-expressing-infected cells through ADCC"/>
  <result pre="secondary infections by another serotype, when serotype-specific neutralizing antibodies to" exact="DENV" post="are present; the four DENV serotypes share 70% sequence"/>
  <result pre="when serotype-specific neutralizing antibodies to DENV are present; the four" exact="DENV" post="serotypes share 70% sequence homology and thus cross-reactivity is"/>
  <result pre="underlying mechanism of elevated immune-pathology associated with severe forms of" exact="DENV" post="[98,99]. This can cause antibody-dependent enhancement (ADE), in which"/>
  <result pre="Diversity, Identity and Cell EntryFront. Immunol.20189218010.3389/fimmu.2018.0218030319635 9.Van Duijl-RichterM.K.HoornwegT.E.Rodenhuis-ZybertI.A.SmitJ.M.Early Events in" exact="Chikungunya" post="Virus Infection-From Virus Cell Binding to Membrane FusionViruses201573647367410.3390/v707279226198242 10.PalhaN.Guivel-BenhassineF.BriolatV.LutfallaG.SourisseauM.EllettF.WangC.H.LieschkeG.J.HerbomelP.SchwartzO.et"/>
  <result pre="Cell Binding to Membrane FusionViruses201573647367410.3390/v707279226198242 10.PalhaN.Guivel-BenhassineF.BriolatV.LutfallaG.SourisseauM.EllettF.WangC.H.LieschkeG.J.HerbomelP.SchwartzO.et al.Real-time whole-body visualization of" exact="Chikungunya" post="Virus infection and host interferon response in zebrafishPLoS Pathog.20139e100361910.1371/journal.ppat.100361924039582"/>
  <result pre="Infect. Dis.201616e119e12610.1016/S1473-3099(16)30010-X27282424 17.AuerswaldH.BoussiouxC.InS.MaoS.OngS.HuyR.LeangR.ChanM.DuongV.LyS.et al.Broad and long-lasting immune protection against various" exact="Chikungunya" post="genotypes demonstrated by participants in a cross-sectional study in"/>
  <result pre="class-I and inhibitory KIR genotypes in Gabonese patients infected by" exact="Chikungunya" post="or Dengue type-2 virusesPLoS ONE20149e10879810.1371/journal.pone.010879825264760 34.BoudreauJ.E.HsuK.C.Natural killer cell education"/>
  <result pre="inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or" exact="Dengue" post="type-2 virusesPLoS ONE20149e10879810.1371/journal.pone.010879825264760 34.BoudreauJ.E.HsuK.C.Natural killer cell education in human"/>
  <result pre="cell memory in infection, inflammation and cancerNat. Rev. Immunol.20161611212310.1038/nri.2015.926806484 43.HotezP.J.MurrayK.O.Dengue," exact="West Nile" post="virus, chikungunya, Zika-and now Mayaro?PLoS Negl. Trop. Dis.201711e000546210.1371/journal.pntd.000546228859086 44.Acosta-AmpudiaY.MonsalveD.M.RodríguezY.PachecoY.AnayaJ.M.Ramírez-SantanaC.Mayaro:"/>
  <result pre="toward cytotoxicityPLoS Pathog.20117e100226810.1371/journal.ppat.100226821966274 46.PetitdemangeC.WauquierN.DevilliersH.YsselH.MomboI.CaronM.NkoghéD.DebréP.LeroyE.VieillardV.Longitudinal Analysis of Natural Killer Cells in" exact="Dengue" post="Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected"/>
  <result pre="Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to" exact="Chikungunya" post="and Chikungunya/Dengue Virus-Infected PatientsPLoS Negl. Trop. Dis.201610e000449910.1371/journal.pntd.000449926938618 47.ThanapatiS.DasR.TripathyA.S.Phenotypic and"/>
  <result pre="stages of chikungunya infectionFront. Microbiol.2015689510.3389/fmicb.2015.0089526388848 48.FoxJ.M.DiamondM.S.Immune-Mediated Protection and Pathogenesis of" exact="Chikungunya" post="VirusJ. Immunol.20161974210421810.4049/jimmunol.160142627864552 49.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent chronic inflammation and"/>
  <result pre="Immunol.20161974210421810.4049/jimmunol.160142627864552 49.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.DenizotM.GuichardE.RiberaA.HenniT.et al.Persistent chronic inflammation and infection by" exact="Chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
  <result pre="CancerCold Spring Harb. Perspect. Biol.20181010a02953810.1101/cshperspect.a029538 61.TeoT.H.HerZ.TanJ.J.LumF.M.LeeW.W.ChanY.H.OngR.Y.KamY.W.Leparc-GoffartI.GallianP.et al.Caribbean and La Réunion" exact="Chikungunya" post="Virus Isolates Differ in Their Capacity To Induce Proinflammatory"/>
  <result pre="osteoarthritisOsteoarthr. Cartil.2017251708171810.1016/j.joca.2017.06.00728668542 64.StrodeG.K.Yellow FeverMcGraw-HillNew York, NY, USA1951 65.JiaX.Y.BrieseT.JordanI.RambautA.ChiH.C.MackenzieJ.S.HallR.A.ScherretJ.LipkinW.I.Genetic analysis of" exact="West Nile" post="New York 1999 encephalitis virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to Dengue"/>
  <result pre="West Nile New York 1999 encephalitis virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to" exact="Dengue" post="and ZikaAnnu. Rev. Immunol.20183627930810.1146/annurev-immunol-042617-05314229345964 67.BecquartP.WauquierN.NkogheD.Ndjoyi-MbiguinoA.PadillaC.SourisM.LeroyE.M.Acute dengue virus 2 infection"/>
  <result pre="hemorrhagic feverJ. Infect. Dis.19991801429143510.1086/31507210515800 75.YaoY.Strauss-AlbeenD.M.ZhouJ.Q.MalawistaA.GarciaM.N.MurrayK.O.BlishC.A.MontgomeryR.R.The natural killer cell response to" exact="West Nile" post="virus in young and old individuals with or without"/>
  <result pre="al.NKp44 receptor mediates interaction of the envelope glycoproteins from the" exact="West Nile" post="and dengue viruses with NK cellsJ. Immunol.20091832610262110.4049/jimmunol.080280619635919 88.LobigsM.MüllbacherA.RegnerM.MHC class"/>
  <result pre="MoleculesJ. Virol.201791e00785-1710.1128/JVI.00785-1728878071 90.ChengY.KingN.J.KessonA.M.Major histocompatibility complex class I (MHC-I) induction by" exact="West Nile" post="virus: Involvement of 2 signaling pathways in MHC-I up-regulationJ."/>
  <result pre="up-regulationJ. Infect. Dis.200418965866810.1086/38150114767820 91.DrewsE.AdamA.HtooP.TownsleyE.MathewA.Upregulation of HLA-E by dengue and not" exact="Zika" post="virusesClin. Transl. Immunol.20187e103910.1002/cti2.1039 92.ZhangM.DanielS.HuangY.ChanceyC.HuangQ.LeiY.F.GrinevA.MostowskiH.RiosM.DaytonA.Anti-West Nile virus activity of in"/>
  <result pre="cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of" exact="West Nile" post="Virus-infected cellsJ. Virol.2007819551955510.1128/JVI.00879-0717582005 98.KhandiaR.MunjalA.DhamaK.KarthikK.TiwariR.MalikY.S.SinghR.K.ChaicumpaW.Modulation of Dengue/Zika Virus Pathogenicity by"/>
  <result pre="by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in" exact="Zika" post="Virus InfectionFront. Immunol.2018959710.3389/fimmu.2018.0059729740424 99.CastanhaP.M.S.NascimentoE.J.M.BragaC.CordeiroM.T.de CarvalhoO.V.de MendonçaL.R.AzevedoE.A.N.FrançaR.F.O.DhaliaR.MarquesE.T.A.Enhancement of Zika Infection"/>
  <result pre="Enhancement in Zika Virus InfectionFront. Immunol.2018959710.3389/fimmu.2018.0059729740424 99.CastanhaP.M.S.NascimentoE.J.M.BragaC.CordeiroM.T.de CarvalhoO.V.de MendonçaL.R.AzevedoE.A.N.FrançaR.F.O.DhaliaR.MarquesE.T.A.Enhancement of" exact="Zika" post="Infection by Dengue-Specific Antibodies Does Not Alter the Production"/>
  <result pre="enhancement of dengue virusesAdv. Virus Res.20036042146714689700 101.SunP.WilliamsM.NagabhushanaN.MorrisonB.J.Combating Antibody-dependent Enhancement of" exact="Dengue" post="Viral infection in Peripheral Blood Monocytes by NK Cell-mediated"/>
  <result pre="(BAGV), Bamaga virus (BGV), Banzi virus (BANV), Bouboui virus (BOUV)," exact="Dengue" post="virus (DENV), Israel Turkey meningoencephalomyelitis (ITV), Japanese encephalitis virus"/>
  <result pre="(TMUV), T’Ho virus (THOV), Usutu virus (USUV), Wesselsbron virus (WESSV)," exact="West Nile" post="virus (WNV), yellow fever virus (YFV) and Zika virus"/>
  <result pre="(WESSV), West Nile virus (WNV), yellow fever virus (YFV) and" exact="Zika" post="virus (ZIKV). Alphaviruses: Barmah forest virus (BFV), Chikungunya virus"/>
  <result pre="(YFV) and Zika virus (ZIKV). Alphaviruses: Barmah forest virus (BFV)," exact="Chikungunya" post="virus (CHIKV), Mayaro virus (MAYV), O’nyong-nyong virus (ONNV), Ross"/>
 </snippets>
</snippetsTree>
